HCPCS Level II · Drugs administered other than oral method
J9340Injection, thiotepa, 15 mg
Terminated 06/30/2025
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About J9340
J9340 is an HCPCS Level II code in the J series (drugs administered other than oral method), describing injection, thiotepa, 15 mg.
It was added to HCPCS effective 01/01/1984, and its current record took effect 07/01/2025.
It was terminated on 06/30/2025 and can't be billed for later dates of service.
Its Medicare coverage code is "D", meaning special Medicare coverage instructions apply.
Details
- Short description
- Thiotepa injection
- Date added
- 01/01/1984
- Action effective
- 07/01/2025
- Termination date
- 06/30/2025
- BETOS
- O1D
Related J93xx codes
- J9301Injection, obinutuzumab, 10 mg
- J9302Injection, ofatumumab, 10 mg
- J9303Injection, panitumumab, 10 mg
- J9304Injection, pemetrexed (pemfexy), 10 mg
- J9305Injection, pemetrexed, not otherwise specified, 10 mg
- J9306Injection, pertuzumab, 1 mg
- J9307Injection, pralatrexate, 1 mg
- J9308Injection, ramucirumab, 5 mg
- J9309Injection, polatuzumab vedotin-piiq, 1 mg
- J9311Injection, rituximab 10 mg and hyaluronidase
- J9312Injection, rituximab, 10 mg
- J9313Injection, moxetumomab pasudotox-tdfk, 0.01 mg
Common questions about J9340
Is HCPCS J9340 still valid?
- No. J9340 was terminated on 06/30/2025.
Does Medicare cover J9340?
- Its coverage code is "D": special Medicare coverage instructions apply. Check the local coverage determination for your region.